Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study

被引：0

作者：

Ghusn, Wissam ^{[1
]}

Fansa, Sima ^{[1
]}

Anazco, Diego ^{[1
]}

Tama, Elif ^{[2
]}

Nicolalde, Bryan ^{[1
]}

Gala, Khushboo ^{[1
]}

Cifuentes, Lizeth ^{[1
]}

De La Rosa, Alan ^{[1
]}

Sacoto, Daniel ^{[1
]}

Campos, Alejandro ^{[1
]}

Feris, Fauzi ^{[1
]}

Acosta, Andres ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Mayo Clin, Jacksonville, FL USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1485

引用

页码：S1127 / S1128

页数：2

共 50 条

[41] Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease
Kraus, Emily M.
Pierce, Samantha Lange
Porter, Renee
Kompaniyets, Lyudmyla
Vos, Miriam B.
Blanck, Heidi M.
King, Raymond J.
Goodman, Alyson B.
CHILDHOOD OBESITY, 2024, 20 (01) : 41 - 47
[42] CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMPARED TO ALCOHOLIC LIVER DISEASE.
Abe, Temidayo
Ajose, Taiwo A.
Ajose, Afolarin
Abe, Tolulope
Patel, Parth
Sobukonla, Timothy
Surapaneni, Phani Keerthi
GASTROENTEROLOGY, 2020, 158 (06) : S346 - S347
[43] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ARE SUBSTANTIAL AND INCREASE WITH ADVANCED DISEASE
Siddiqui, Mohammad B.
Myers, Joel
Byrne, Clare
Wang, Yuexi
Tang, Jackson
Ogbomo, Adesuwa
Qiu, Ying
HEPATOLOGY, 2020, 72 : 990 - 990
[44] Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
Yamamura, Sakura
Nakano, Dan
Hashida, Ryuki
Tsutsumi, Tsubasa
Kawaguchi, Takumi
Okada, Michiaki
Isoda, Hiroshi
Takahashi, Hirokazu
Matsuse, Hiroo
Eguchi, Yuichiro
Sumida, Yoshio
Nakajima, Atsushi
Gerber, Lynn
Younossi, Zobair M.
Torimura, Takuji
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (03) : 629 - 636
[45] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
Burke, A
Lucey, MR
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
[46] Performance of non-invasive biomarkers and transient elastography for predicting liver fibrosis in patients with non-alcoholic fatty liver disease: A real-world evaluation
Zhu, J.
Majeed, A.
Roberts, S.
Kemp, W.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 88 - 88
[47] Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?
Merli, Manuela
Dasarathy, Srinivasan
JOURNAL OF HEPATOLOGY, 2015, 63 (02) : 309 - 311
[48] No association exists between non-alcoholic fatty liver disease and dementia risk: A meta-analysis of real-world evidence
Hussain, Mohammad Salman
Klugarova, Jitka
Klugar, Miloslav
JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 140 - 140
[49] Towards collaborative management of non-alcoholic fatty liver disease: a 'real-world' pathway for fibrosis risk assessment in primary care
Hayward, Kelly L.
McKillen, Benjamin J.
Horsfall, Leigh U.
McIvor, Carolyn
Liew, Katerina
Sexton, Jo
Johnson, Amy L.
Irvine, Katharine M.
Valery, Patricia C.
McPhail, Steven M.
Britton, Laurence J.
Rosenberg, William
Weate, Ingrid
Williams, Sue
Powell, Elizabeth E.
INTERNAL MEDICINE JOURNAL, 2022, 52 (10) : 1749 - 1758
[50] NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC FATTY PANCREAS DISEASE: A NEW INTRIGUING ASSOCIATION?
Della Corte, Claudia
Mosca, Antonella
Sartorelli, Maria Rita
Comparcola, Donatella
Liccardo, Daniela
Alterio, Arianna
Lucidi, Vincenzina
Nobili, Valerio
DIGESTIVE AND LIVER DISEASE, 2014, 46 : E101 - E101

← 1 2 3 4 5 →